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A novel vaccine against bovine viral diarrhea (BVD) induced pathogenic antibody
production in 5–10% of BVD-vaccinated cows. Transfer of these antibodies via colostrum
caused Bovine neonatal pancytopenia (BNP) in calves, with a lethality rate of 90%. The
exact immunological mechanisms behind the onset of BNP are not fully understood to
date. To gain further insight into these mechanisms, we analyzed the immune proteome
from alloreactive antibody producers (BNP cows) and non-responders. After in vitro
stimulation of peripheral blood derived lymphocytes (PBL), we detected distinctly deviant
expression levels of several master regulators of immune responses in BNP cells, pointing
to a changed immune phenotype with severe dysregulation of immune response in BNP
cows. Interestingly, we also found this response pattern in 22% of non-BVD-vaccinated
cows, indicating a genetic predisposition of this immune deviant (ID) phenotype in cattle.
We additionally analyzed the functional correlation of the ID phenotype with 10 health
parameters and 6 diseases in a retrospective study over 38 months. The significantly
increased prevalence of mastitis among ID cows emphasizes the clinical relevance of
this deviant immune response and its potential impact on the ability to fight infections.
Keywords: bovine neonatal pancytopenia, hyperproliferation, differential immune proteome, Concanavalin A,
STAT, T helper pathways, deviant immune phenotype, mastitis
INTRODUCTION
Vaccines are the most effective and also affordable disease-prevention tools (1) and maternal
antibodies protect the offspring from infections in man (2) and animals (3). In cattle, pre-partum
vaccination with various virulence factors of bacterial or viral infectious diseases is a standard
procedure which effectively stimulates the production of specific antibodies (4, 5). A novel
production technology using an allogeneic cell line (6) and the addition of a highly potent
adjuvant to PregSure BVD, a new vaccine against bovine viral diarrhea (BVD), induced fatal
immune reactions with production of alloreactive antibodies in 5–10% of vaccinated cows (7–9).
These alloantibodies were transmitted to calves, regardless of kin, via the colostrum of these
dams (8, 10) and caused bovine neonatal pancytopenia (BNP) (7, 11–13), even years after the
vaccine has been taken off the market (14). BNP calves suffered from hemorrhagic diathesis,
thrombo and leukocytopenia and bone marrow depletion, which resulted in a deadly bleeding
disorder (10, 15, 16). Several authors hypothesized alloimmune reactions against the major
histocompatibility complex class I (MHC I) as causal for BNP (17–20). This hypothesis is still
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controversial since MHC I alloantibodies would be expected
to bind all nucleated cells, not only to blood-derived and
hematopoietic progenitor cells (12, 16). Also transcriptome
analyses provided evidence that MHC I can be excluded as single
causal agent for BNP-associated alloantibodies (21). As other
authors claimed the possibility of a genetic predisposition of
BNP dams for production of BNP inducing alloantibodies (22–
24), our studies focused on investigating a general difference in
immune responses between PregSure BVD vaccinated control
cows and BNP donors. We wanted to analyze if there is
evidence for differential expression of master transcription
factors of cellular immune response in lymphocyte proteome
of controls and BNP dams. Interestingly, we found a markedly
different immune phenotype in BNP dams, characterized by
significant hyperproliferation of lymphocytes and a deviant
immune signaling pathway compared to controls. We were next
interested to see if we could find evidence for this immune
phenotype in cows that were never vaccinated with PregSure
BVD. Further testing showed that this altered immune phenotype
was also detectable in 22% of cows from a PregSure BVD
unvaccinated cohort. This confirmed its natural, not vaccine-
induced, appearance in cattle and gave more evidence for
immune deviant (ID) phenotype as a genetic predisposition. In
further in-depth experiments we found that Interleukin-2 (IL-
2) plays an important role in diverging immune response of ID
lymphocytes. In addition to these immune response studies, we
analyzed the functional correlation of the ID phenotype with
overall 10 health parameters and 6 diseases in a retrospective
study over 38 months. Here, a significantly increased mastitis
incidence in cows with an ID phenotype became apparent,
highlighting the clinical impact of altered immune response.
MATERIALS AND METHODS
In this study, peripheral blood derived lymphocytes (PBL) of
a total of 132 cows were used. Eleven of these cows had
previously been vaccinated with PregSure BVD, of which six
did not produce BNP-inducing antibodies (BVD vaccinated
control cows) and five showed alloreactive antibody production
(BNP dams) resulting in their calves dying from hemorrhagic
diathesis with confirmed thrombocytopenia, leukocytopenia and
bone marrow depletion. The remaining 121 cows were healthy
controls (female, age: 2–10 years, first to eight lactation period)
from one dairy farm never vaccinated with PregSure BVD. No
experimental animals were killed through this study. Withdrawal
of blood was permitted by the local authority Regierung von
Oberbayern, Munich, permit no. 55.2-1-54-2532.3-22-12.
PBL Isolation
Bovine venous blood samples were collected in tubes with
heparin sodium 25.000 I.U.. Blood was diluted with equal parts
Abbreviations:BanLec, Banana lectin; BNP, Bovine neonatal pancytopenia; ConA,
Concanavalin A; CD, Cluster of differentiation; ID, Immundeviant phenotype;
IFNγ, Interferon gamma; IL, Interleukin; JAK, Janus kinase; MHC I, major
histocompatibility complex class I; PBL, peripheral blood lymphocytes; PWM,
Pokeweed Mitogen; STAT, Signal transducer and activator of transcription; Tfh,
follicular T helper cells; Th, T helper cells; Tr, regulatory T helper cells.
of phosphate buffered saline (PBS; 136,9mM NaCl, 2,6mM
KCl, 1,4mM KH2PO4, 8,1mM Na2HPO4 × 2H2O; pH 7,2)
and subsequently layered on density gradient separating solution
(Pancoll; PanBiotech, Aidenbach, Germany). After density
gradient centrifugation (room temperature, 290 × g, 25min,
brake off), PBL were obtained from intermediate phase. Cells
were washed twice in PBS (4◦C) and either used immediately or
stored at−20◦C (lysate) for western blot analyses.
Proliferation Assays
PBL were seeded in 96-well plates (1 × 105 cells/well) and
stimulated for 48 h with either PWM (Pokeweedmitogen), ConA
(Concanavalin A) or BanLec (Banana lectin) (Sigma-Aldrich,
Taufkirchen, Germany, 5µg/ml), bovine IL-2 (Bio-Techne,
Wiesbaden, Germany, 1 ng/ml), bovine IL-4 or bovine Interferon
gamma (IFNγ) (Thermo Fisher Scientific, Bremen, Germany,
3 ng/ml). For the inhibition assays, cells were incubated with
STAT3 inhibitor (WP 1,066, Santa Cruz, Heidelberg, Germany,
50 ng/ml) 12 h before stimulation. After 34 h of stimulation, cells
were pulsed for 14 h with 0,05 mCi/well [methyl-3H]-thymidine
(Perkin Elmer, Hamburg, Germany), harvested and counts per
minute were measured. Proliferation rate after stimulation was
expressed as factor of [3H]-thymidine incorporation with respect
to the unstimulated cells or after inhibition as percentage to
ConA stimulated cells.
Flow Cytometry Analyses
Staining of 5× 105 cells per well was performed with anti-bovine
cluster of differentiation (CD) 4 (mouse IgG1 monoclonal,
Bio-Rad AbD Serotec, Puchheim, Germany; 1:100), anti-bovine
CD8 (mouse IgG2a monoclonal, Bio-Rad AbD Serotec; 1:50)
and FITC-conjugated anti-bovine IgM (Bio-Rad AbD Serotec,
Puchheim, Germany; 1:50) antibodies, diluted in staining buffer
(1% BSA + 0,001% NaN3 in PBS). Respective secondary
antibodies anti-mouse IgG1 FITC and anti-mouse IgG2a FITC
(both Santa Cruz Biotechnology; Heidelberg, Germany 1:200)
were added. All antibodies were incubated for 30min on ice. Cells
were washed with staining buffer between primary and secondary
antibody staining steps (200 × g, 4◦C, 1min). For all stainings
with secondary antibodies respective isotype controls were used.
Cells were fixed in 1% PFA diluted in staining buffer and stored
at 4◦C until analysis. On FACS Canto II, measurement of cells
was performed with FACS Diva Software (BD Biosciences).
Lymphocytes were gated according to forward scatter (cell size)
and side scatter (intercellular granularity) properties of cells. Per
staining, between 5 × 103 and 1 × 104 cells were measured.
Further analysis of flow cytometry data was performed using
open source Flowing Software 2.5.1 http://flowingsoftware.btk.fi/
(Perttu Terho, Turku Centre for Biotechnology, Finland).
Differential Proteome Analyses
PBL (2.2 × 107 cells) of two PregSure BVD vaccinated control
cows and two BNP dams were stimulated with PWM and
ConA (5µg/ml) for 48 h. For LC-MS/MS analysis, peptides were
separated on a reversed chromatography column (75µm ID
× 15 cm, Acclaim PepMAP 100 C18. 100Å/size, LC Packings,
Thermo Fisher Scientific, Bremen, Germany) and the analysis
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was conducted with an Ultimate 3000 nano-HPLC system
(Dionex, Idstein, Germany). Nano-HPLC was connected in a
linear quadruple ion trap-Orbitrap (LTQ Orbitrap XL) mass
spectrometer (Thermo Fisher Scientific, Bremen, Germany).
The mass spectrometer was operated in the data-dependent
mode to automatically switch between Orbitrap-MS and LTQ-
MS/MS acquisition. Up to 10 most intense ions were selected
for fragmentation on the linear ion trap using collision induced
dissociation at a target value of 100 ions and subsequently
dynamically excluded for 30 s. Elevated spectra were imported
into Progenesis software (version 2.5). After comparison and
normalization, spectra were exported as Mascot Generic files and
searched against the Ensembl bovine database (version 80) with
Mascot (Matrix Science, version 2.4.1). Peptide assignment was
reimported to Progenesis Software. All unique peptides allocated
to a protein were considered for quantification. Only proteins
quantified with at least two peptides were included for further
analysis.
For hierarchical cluster analyses of normalized protein
abundances, arithmetic means of two respective vaccinated
control and BNP samples were generated and proteins with
similar expression patterns were clustered with Perseus software
algorithm (version 1.6.1.1; Computational Systems Biochemistry,
Martinsried, Germany) (25). Proteins with a ratio of at least 2-
fold in normalized abundance between control and BNP samples
were defined as differentially.
Western Blots
For protein expression analyses with western blots, PBL
were first lysed in lysis buffer (9M Urea, 2M Thiourea,
65mM Dithioerythritol, 4% CHAPS). Proteins were then
separated by SDS-PAGE on 8% gels (7 µg protein/slot)
and blotted semidry onto 8.5 × 6 cm PVDF membranes
(GE Healthcare, Freiburg, Germany) and blocked with 4%
BSA (1 h). Blots were incubated overnight with respective
primary antibodies: rabbit anti-pSTAT1 Tyr701, rabbit anti-
pSTAT3 Tyr705 (Cell Signaling, Darmstadt, Germany, 1:500)
or mouse anti-beta actin (Sigma, Taufkirchen, Germany,
1:5000). As secondary antibodies, either HRP-coupled goat
anti-rabbit IgG (H+L) antibody (Cell Signaling, Darmstadt,
Germany, 1:5000) or goat anti-mouse IgG (H+L) antibody
(Sigma-Aldrich, Taufkirchen, Germany, 1:5000) were used (1 h).
Signals were detected by enhanced chemiluminescence on X-
ray film (SUPER-2000G ortho, Fuji; Christiansen, Planegg,
Germany). Films were scanned on a transmission scanner
and densitometric quantification of Western blot signals
was performed using ImageJ software (open source: http://
imagej.nih.gov/ij/). Abundances of pSTAT1 and pSTAT3 were
subsequently normalized to beta actin.
Health Parameters
Milk production and health parameters (observed by
veterinarians) of 100 non-PregSure BVD vaccinated cattle from
one dairy farm were analyzed for 38 months retrospectively.
Results were then correlated to immune response data
of in vitro assays. Seventy-three control cows with low
proliferation rate after ConA stimulation and 27 ID cows,
which showed a BNP-like hyperproliferation to ConA,
were included in this study. Ten health parameters [daily
milk yield, average lactation performance (300 days), milk
structure (lactose, fat, urea, somatic cell count), fertility
parameters (amounts of inseminations, calving-to-conception
intervals, medicinal induction of oestrus, ovarian cysts)]
and 6 diseases [diseases of musculoskeletal system, claws,
digestive tract, respiratory system, and metabolic disorders
(ketosis, hypocalcemia)] were analyzed. All parameters were
recorded and listed by the same veterinarians and the statistical
analysis was performed using the odds ratio and chi-square
distribution.
Statistical Analyses
Data were analyzed in Prism software (GraphPad, version
5.04) with Kolmogorow-Smirnow (KS) test. If KS test was
significant (p < 0.05; normal distribution), Student’s t-test
was used for statistical analysis, if KS test was not significant
(p > 0.05; no normal distribution) statistics were performed
using Mann-Whitney test. For statistical analysis of health
parameters, we used odds ratio and chi-square distribution.
Differences were considered statistically significant with the
following p-values: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and
∗∗∗∗p < 0.0001.
RESULTS
Lymphocytes of BNP Dams Show
Hyperproliferation After Polyclonal
Stimulation in vitro
After in vitro stimulation (48 h) with T and B cell mitogen
PWM (26) and T cell mitogen ConA (27), a clearly
divergent reaction of lymphocytes from PregSure BVD
vaccinated cows became evident. Cells from cows known to
produce alloreactive BNP antibodies after vaccination (BNP
FIGURE 1 | Hyperproliferation of BNP lymphocytes after polyclonal stimulation
in vitro. (A) Lymphocytes from BNP cows (black bars, n = 5, technical
replicates n = 98) proliferated 4.5 times stronger (****p < 0.0001 vs. control)
after PWM stimulation than lymphocytes from control dams (white bars, n = 6,
technical replicates n = 53). (B) Increased proliferation rate (8-fold;
****p < 0.0001 vs. control) of lymphocytes from BNP dams (black bars, n = 5,
technical replicates n = 86) compared to control dams (white bars, n = 6,
technical replicates n = 52) after in vitro stimulation with ConA. Proliferation
rate shown in mean ± SD. Mann-Whitney test was used.
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lymphocytes) proliferated significantly stronger (4.5-fold) than
cells from vaccinated control dams after PWM stimulation
(Figure 1A, BNP to Ctr, ∗∗∗∗p < 0.0001) and ConA stimulation
(8-fold stronger; Figure 1B, BNP to Ctr, ∗∗∗∗p < 0.0001).
Thus, in vitro proliferation assays revealed a highly significant
hyperproliferation of BNP lymphocytes demonstrating an
FIGURE 2 | No differences in distribution of lymphocyte subsets between control and BNP dams. (A–J) Representative dot plots of flow cytometry analyses from
lymphocytes of control and BNP cows. (A) Identification of lymphocytes (Lymph) based upon properties of forward (FSC) and sideward scatter (SSC). The population
to be measured is shown in red (lymphocytes). (B) Unstained cells in Q3 to determine position of quadrants for gating. (C–J) Respective staining shown in Q4.
(C) Expression of CD4 in control lymphocytes (45%). (D) Expression of CD4 in BNP lymphocytes (50%). (E) Respective isotype control staining for CD4 antibody
(mIgG1, 1%). (F) Expression of CD8 in control lymphocytes (28%). (G) Expression of CD8 in BNP lymphocytes (27%). (H) Respective isotype control staining for CD8
antibody (mIgG2a, 1%). (I) Expression of B cell marker IgM in control lymphocytes (25%). (J) Expression of B cell marker IgM in BNP lymphocytes (20%). (K) Flow
cytometry analyses of lymphocyte subset distribution revealed no significant differences (ns) between control (white bars; n = 4) and BNP cells (black bars; n = 3).
Percentage of subset is shown in mean ± SD. For statistical analyses Mann-Whitney test was used.
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FIGURE 3 | Lymphocyte proteomes reveal regulation of differential expression of proteins between normal and deviant immune responders to PregSure BVD
vaccination. Differential proteome analyses of PBL from control (Ctr, n = 2, shown as arithmetic means) and BNP (n = 2, shown as arithmetic means) cows already
revealed differences in protein expression patterns in constitutive expression (cE) of proteins, that shifted even stronger after (A) PWM and (B) ConA stimulation (48 h).
Highly abundant proteins are presented in green and low abundant proteins in red. (C/D) In-depth analysis of part of the proteome relating to regulation of immune
cells revealed some differentially (factor ≥ 2.0) expressed STAT proteins in bovine PBL after polyclonal activation with PWM (C) or ConA (D). STAT3 and STAT5A were
selectively upregulated in BNP lymphocytes (C) compared to controls due to PWM. After ConA stimulation, controls significantly upregulated STAT1 and STAT6
(D), whereas in PBL of BNP cases STAT3 was enhanced during immune response (D).
increased reaction to polyclonal immune stimulation in these
cows.
No Significant Differences in Lymphocyte
Subsets Were Detectable
To exclude differences in lymphocyte subset percentages between
control and BNP dams as a possible cause for the differential
responses toward polyclonal immune stimulation, we analyzed
the distribution of CD4+, CD8+, and B cells in control
and BNP PBL. There were no significant differences in
proportional composition of subpopulations between PregSure
BVD vaccinated control and BNP animals (Figure 2).
Lymphocyte Proteomes Reveal Differential
Protein Regulation Between Normal And
Deviant Immune Responders to PregSure
BVD Vaccination
To investigate if observed deviant reactions to in vitro stimulation
originated from differences in immune cell regulation, we
executed a differential proteomics experiment with PWM
and ConA treated lymphocytes as well as unstimulated
cells. Overall, we detected 5,471 proteins. Hierarchical cluster
analysis of complete proteomes already visualized fundamental
differences in protein abundances between PregSure BVD
vaccinated control and BNP cows in constitutive protein
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FIGURE 4 | In PBL of control and BNP cows, different transcription factors were activated after ConA stimulation in vitro. (A) Representative western blot of
constitutive (cE) pSTAT1 Tyr701 expression and after stimulation with ConA (ConA) in control PBL (Ctr, n = 1) and BNP PBL (BNP, n = 1). (B) Lymphocytes of
vaccinated control cows (white-black striped bars, n = 5) phosphorylated STAT1 Tyr701 significantly stronger than BNP lymphocytes (black-white striped bars, n = 5)
after ConA stimulation (**p < 0.01). (C) Representative western blot of constitutive (cE) pSTAT3 Tyr705 expression and after stimulation with ConA (ConA) in control
PBL (Ctr, n = 1) and BNP PBL (BNP, n = 1). (D) BNP lymphocytes (black-white striped bars, n = 5) phosphorylated STAT3 Tyr705 comparatively stronger than
vaccinated control lymphocytes (white-black striped bars, n = 5) in response to ConA stimulation (*p < 0.05). (A/C) Phosphorylated STAT1 Tyr701 and pSTAT3
Tyr705 signals were normalized to beta-actin and quantified using Image-J software. Protein expression is shown in mean ± SD. For statistical analyses Student‘s t
test was performed.
levels (cE, Figures 3A,B). Differences in protein expression
were also confirmed after immune stimulation (PWM and
ConA, Figures 3A,B, hierarchical clustering of all identified
proteins). These proteome analyses therefore revealed substantial
quantitative differences on protein level.
Immune Stimulation Leads to Different
Usage of STAT Pathways in PBL of Control
and BNP Cows
Next, we used our dataset to perform more in-depth analyses
on part of the proteome involved in transcription pathways of
immune cell regulation. To identify possible differences inmaster
transcription factor expression, we compared lymphocytes from
vaccinated control and BNP cows after polyclonal in vitro
stimulation. Signal transducers and activators of transcription
(STAT) induce different T helper (Th) responses in mice and
man (24) as master transcription factors. Therefor we analyzed
all identified STATs from both proteomic approaches and
characterized usage of different STAT pathways as a response
to immune stimulation in both cow groups. After polyclonal
activation of lymphocytes with PWM, STAT3 and STAT5A
were selectively upregulated at least 2-fold in BNP lymphocytes
(Figure 3C). ConA stimulation of control cells, however, caused
upregulation of STAT1 and STAT6 expression levels (Figure 3D),
whereas BNP PBL showed enhanced STAT3 in immune response
(Figure 3D). Thus, control and BNP PBL upregulated different
master transcription factors as response to stimulation pointing
to usage of different immune pathways.
Lymphocytes of Control and BNP Cows
Regulate Different STATs in Response to
ConA Stimulation in vitro
Since we decided to further analyze the differential activation
of STATs through T cell mitogen ConA, we determined
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FIGURE 5 | STAT3 inhibitor WP1066 selectively inhibits hyperproliferation of
lymphocytes from BNP cows. STAT3 inhibitor did not inhibit proliferation of
control PBL (white bar, n = 4), but significantly inhibited ConA stimulated BNP
cells (black bars, n = 4, ***p < 0.001). Percentage of inhibition rate shown in
mean ± SD. Student‘s t-test was used for statistical analyses.
phosphorylation of STAT1 and STAT3 in response to
immune stimulation. In lymphocytes of vaccinated controls,
phosphorylation of STAT1 Tyr701 significantly increased
after in vitro stimulation with ConA compared to BNP
PBL, where STAT1 Tyr701 phosphorylation decreased after
ConA stimulation (Figures 4A,B, Ctr to BNP after ConA
stimulation, ∗∗p < 0.01). In contrast, lymphocytes of BNP dams
phosphorylated STAT3 Tyr705 comparatively stronger than PBL
of vaccinated control cows after ConA (Figures 4C,D, BNP to
Ctr after ConA stimulation, ∗p < 0.05). Thus, these experiments
ascertained a qualitative difference in immune reactions between
the cow groups to a T cell stimulus.
Inhibition of STAT3 in PBL of BNP Cows
Abolishes Hyperproliferation as Reaction
to Polyclonal Immune Stimulation
Since BNP lymphocytes responded to polyclonal stimulation
with hyperproliferation and activation of STAT3, we next tested
if inhibition of STAT3 reversed respective hyperproliferation.
WP1066 (STAT3 inhibitor) significantly reduced proliferation of
BNP lymphocytes after ConA stimulation (Figure 5, inhibition
of BNP compared to Ctr, ∗∗∗p < 0.001), but not of control
lymphocytes. This verified the importance of STAT3-pathway
for the hyperproliferation in BNP PBL after polyclonal T cell
stimulation.
Immune Deviant Phenotype Is Also
Detectable in Unvaccinated Cows
Since we first detected the deviant immune phenotype in BNP
cows, we next tested cows that were never vaccinated with
PregSure BVD in order to clarify whether the deviant phenotype
was induced through vaccination or if it occurs naturally in
a certain subset of cows. Therefore, we examined response of
lymphocytes to different polyclonal stimuli in a large group of
PregSure BVD unvaccinated cows. To exclude differences caused
by environmental factors, cows all came from the same farm.
In in vitro proliferation assays with T cell mitogen ConA we
observed that 22% of the unvaccinated cows reacted similar to
BNP dams by showing a hyperproliferative reaction to ConA
(immune deviant (ID) phenotype; Figure 6A, reaction difference
ID to controls or BNP to controls, ∗∗∗∗p < 0.0001). Lymphocytes
from ID cows with a hyperproliferative immune phenotype did
not show significant differences to lymphocytes of BNP cows in
these assays (Figure 6A, reaction difference BNP to ID). These
data confirmed the natural occurrence of this ID phenotype
in cattle and gave stronger evidence for genetic predisposition
instead of vaccine-induced appearance.
Lymphocytes of ID Cows Also React to
BanLec and IL-2 With Hyperproliferation
In order to further characterize the pathway targeted by the
polyclonal activators PWM and ConA we tested additional
mitogens. The T cell mitogen BanLec (28), which activates
human T cells through the IL-2 pathway (29, 30), led to
similar hyperproliferation of PBL from BNP dams as observed
with ConA (Figure 6A, reaction difference factor: 5.0, BNP to
controls, ∗∗∗∗p < 0.0001). PBL of ID cows responded to BanLec
stimulation with a similar immune response intensity as BNP
cows (Figure 6B, reaction difference factor: 3.0, ID compared to
controls, ∗∗∗∗p < 0.0001). The reaction of lymphocytes showed
no significant differences between ID and BNP cows. Since the
results with ConA and BanLec pointed to a response via IL-2
pathway, we next tested stimulation with purified bovine IL-
2 only. After IL-2 stimulation, lymphocytes of ID cows also
reacted excessively (Figure 6C, reaction difference factor: 3.1,
ID to controls, ∗∗∗∗p < 0.0001) and did not show significant
differences to BNP lymphocytes (Figure 6C, reaction difference
factor: 3.7, BNP to controls, ∗∗∗∗p < 0.0001).
IL-2, but Not IFNγ or IL-4 Promote the
Different Immune Response in ID Cows
Finally, we tested further signature cytokines for different
Th immune responses, bovine Interferon gamma (IFNγ;
Th1) and Interleukin 4 (IL-4; Th2), to analyze differentiation
of T helper subsets. We detected no significant differences
between lymphocytes of vaccinated and unvaccinated
controls and BNP cases after IFNγ or IL-4 stimulation
in vitro (Figures 6D,E). This proves a crucial role for
IL-2 in the deviant immune responses, but not for IFNγ
or IL-4.
Immune Deviant Phenotype in Cows
Correlates With Significantly Increased
Incidence of Mastitis
In this study, the proliferative phenotype of controls and ID
cows could be repeatedly tested during an overall observation
period of 38 months. All of the sampled immune deviant
cows showed hyperproliferative reaction to ConA at least three
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FIGURE 6 | Immune deviant phenotype also detectable in unvaccinated cows. (A) In in vitro proliferation assays, 22% of unvaccinated cows showed a BNP-like
hyperproliferative reaction to ConA [****p < 0.0001 vs. Ctr (white bar, n = 121)]. Lymphocytes from ID cows (gray bars, n = 27) with a hyperproliferative immune
phenotype showed no significant (ns) differences to lymphocytes of BNP cows (black bars, n = 4, technical replicates n =86). (B) After BanLec stimulation, ID
lymphocytes reacted hyperproliferative in comparison to control lymphocytes (****p < 0.0001) and the proliferation rates of these ID lymphocytes did not show
significant differences (ns) compared to BNP lymphocytes. (C) After IL-2 stimulation, lymphocytes of ID cows also reacted excessively (****p < 0.0001 vs. Ctr) just like
lymphocytes from BNP donors (ns). (D/E) After bovine IFNγ (D) and IL-4 (E) stimulation, no significant differences between lymphocytes of unvaccinated and BNP
cows were determined (ns). Proliferation rate shown in mean ± SD. Student‘s t-test was used.
times. Overall, two-thirds of the ID animals consistently showed
significant differences in their immune response compared to
the unvaccinated control cows (Figure 7A). Since we wanted
to know if this newly discovered immune deviant phenotype
related to impaired health parameters in respective cows, we
retrospectively analyzed milk production, health parameters
and different diseases of control and ID cows from the same
farm never vaccinated with PregSure BVD. From a total of 16
parameters tested, there was no difference in 15 parameters.
However, mastitis incidence was significantly different between
both cow groups. We detected that ID cows suffered from
mastitis twice as often as control cows (Figure 7B, ∗p < 0.05).
At the moment of blood sampling, all cows were clinically
healthy and showed no signs of mastitis which could potentially
influence adverse effects to immune stimulation. Thus, this
clearly indicates that the hyperproliferative phenotype of ID
cows has clinical relevance apart from the response to the BVD
vaccine.
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FIGURE 7 | Proliferation response types remain consistent and ID have a significantly increased incidence of mastitis. (A) The hyperproliferative phenotype of BNP
cows (black) and ID cows (gray) as well as the low proliferation of control cows (white) were consistently detectable over the entire observation period (38 months).
Three representative control cows and ID cows are shown and two BNP cows, white symbols = controls, gray symbols = ID, black symbols = BNP. (B) ID cows
(gray, n = 27) suffered twice as often (difference in incidence *p < 0.05) from mastitis than the control cows (white, n = 73). Incidence of mastitis shown in percent.
Odds ratio and chi-square distribution was used for statistical analyses.
DISCUSSION
BNP was the unwanted result of a fatal immune response to
vaccination with PregSure BVD (8, 9). Five to ten percentage
of vaccinated cattle produced disease inducing antibodies which
were transferred via colostrum, killing 90% of receiving calves,
regardless of kin (15, 31). It is still unclear, why a certain
subgroup of cows responded differently to the vaccination. We
hypothesize that the origin of this altered immune response
lies in the existence of a naturally occurring deviant immune
phenotype. In this study, we could effectively confirm a
quantitative difference in immune cell activation of BNP PBL
through hyperproliferative responses in vitro (Figures 1A,B).
A shift in lymphocyte subpopulations (CD4+, CD8+, B cells)
as a potential reason for these differential responses toward
polyclonal immune stimulation could be excluded (Figure 2).
The hierarchical clustering of identified lymphocyte proteins
from our shotgun proteomics experiment substantiated a general
quantitative difference in constitutive expression of proteins
in PBL of controls and BNP dams (cE, Figures 3A,B). After
immune stimulation, these differences increased even further
(PWM/ConA, Figures 3A,B). In order to perform more in-
depth investigations of potential functional differences, we
subsequently focused on the analysis of master transcription
factors of immune cell regulation from our dataset. As a result,
we detected several differentially expressed STATs. STATs initiate
the differentiation of various Th cell subsets (24) as first-
response master regulators and provide lineage specificity by
promoting the differentiation of a given Th cell subset while
opposing the differentiation to alternative Th cell subsets (32).
This makes them especially interesting to us, since expression
of different STATs in controls and BNP specimen indicates
divergent immune response pathways in these groups. In control
lymphocytes we identified STAT1 with increased expression
(Figure 3D) and significantly higher activation (Figures 4A,B)
after T cell stimulation with ConA. In mice and man, STAT1
is important for the differentiation of naive CD4+ T cells to
Th1 cells (33) or to type 1 regulatory (Tr) T cells (34). From
these findings, we conclude that after immune stimulation,
bovine control lymphocytes use the STAT1 pathway and we
hypothesize that control cows react with a Th1 or Tr immune
response in polyclonal stimulation assays. The effect of STAT1
inhibition could not be tested, since we found no STAT1
specific inhibitor that was commercially available. In contrast to
controls, PBL proteome of BNP dams showed higher expression
levels of STAT3 (Figure 3D), with increased phosphorylation
(Figures 4C,D) in BNP lymphocytes after immune stimulation.
STAT3 could therefore be a possible master regulator for the
deviant immune response in BNP dams. In mouse and man,
STAT3 induces the development of follicular Th (Tfh), Th17,
and Th22 cells (32, 35, 36). Our findings proved a STAT3
pathway dependent immune response of BNP lymphocytes after
polyclonal stimulation, but so far it is unknown which Th subsets
exactly are regulated by STAT3 in cows. The dependence of
the hyperproliferative phenotype of immune deviant PBL on
STAT3 was shown by inhibition of respective factor using WP
1,066, a cell permeable tyrphostin analog which blocks the STAT3
pathway through inhibition of Janus kinase 2 (JAK2) protein
tyrosine kinase (37). As a result, we observed a significantly
reduced proliferation to 37% in BNP PBL, but no effect in
control PBL (Figure 5). Our findings therefore show, that the
deviant immune response of BNP donors is associated with
STAT3/JAK2 pathway. Further studies will be needed to clarify
whether immune cells from control cows differentiate to Th1
or Tr subsets and if BNP donor cows develop Tfh, Th17,
or Th22 cells after immune stimulation. Hyper-reactivity of
BNP PBL and the STAT3 driven differentiation of Tfh cells
after immune stimulation are supported by findings of other
research groups, describing higher alloantibody levels in BNP
cows compared to PregSure BVD vaccinated control dams
(22). This group also hypothesized, that differences between
BNP and control dams are likely due to genes controlling the
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quantitative alloantibody response after vaccination (22). To find
evidence for a genetic predisposition of this immune deviant
BNP phenotype in cows (22, 23), we additionally analyzed
the immune phenotypes of 121 non-PregSure BVD vaccinated
cows. In our study, 22% of cows (ID cows) showed a BNP-like
hyperproliferative response to T cell stimulation in vitro (ID,
Figures 6A,B). This percentage fits to the findings of Benedictus
et al., who hypothesized a heritability of 19% in dams for
the development of BNP in the calf (22). This proves the
existence of an immune deviant phenotype among a certain
subpopulation of cattle, which is not triggered by vaccination
with PregSure BVD but occurs naturally. The immune deviant
response described here in these ID cows clearly depends on IL-
2 (Figure 6C), which we could prove through hyperproliferative
response of BNP and ID lymphocytes to stimulation with BanLec
(Figure 6B), a mitogen that activates human T cells (28, 30)
via the IL-2 pathway (29). For bovine T cells, the specific
impact of IL-2 itself was not described so far. In man and mice,
however, IL-2 has pleiotropic autocrine or paracrine functions
that regulate proliferation of T cells (38). It also plays a key
role in promoting development, homeostasis and function of
regulatory T cells though IL-2/STAT5 signals (39) and balances
expression of different STATs in Th cells of mice (40). Therefore,
the association of IL-2 with the immune deviant response in
cows is a very interesting finding which merits further in-depth
investigations in future studies. To determine whether the newly
detected deviant immune phenotype is of clinical relevance,
we analyzed 10 clinical parameters and 6 diseases in 100 cows
from the sampled dairy farm and compared incidence between
controls (n = 73) and ID animals (n = 27). Interestingly,
we found a significantly increased mastitis incidence in ID
cows compared to controls (Figure 7B). This highly important
correlation points to an altered immune reaction of ID cows to
classical mastitis pathogens, facilitating mastitis onset in these
animals.
In conclusion, we could prove the existence of an immune
deviant phenotype in 22% of cattle, regardless of the vaccination
status. The ID phenotype shows altered reactions to immune
stimulation identical to BNP dams, such as hyperproliferation
of lymphocytes, STAT3/JAK2 regulated pathway and association
with IL-2. These features potentially triggered alloantigen-
production after maternal PregSure BVD vaccination, causing
BNP. The correlation of the ID phenotype with high mastitis
incidence (Figure 7B) underlines its clinical relevance.
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